The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Open accessAbstract
G protein-coupled receptor hetero-oligomerization is emerging as an important regulator of ligand-dependent transmembrane signaling, but precisely how receptor heteromers affect receptor pharmacology remains largely unknown. In this study, we have attempted to identify the functional significance of the heteromeric complex between CXCR4 and CXCR7 chemokine receptors. We demonstrate that co-expression of CXCR7 with CXCR4 results in constitutive recruitment of β-arrestin to the CXCR4·CXCR7 complex and simultaneous impairment of Gi-mediated signaling. CXCR7/CXCR4 co-expression also results in potentiation of CXCL12 (SDF-1)-mediated downstream β-arrestin-dependent cell signaling pathways, including ERK1/2, p38 MAPK, and SAPK as judged from the results of experiments using siRNA knockdown to deplete β-arrestin. Interestingly, CXCR7/CXCR4 co-expression enhances cell migration in response to CXCL12 stimulation. Again, inhibition of β-arrestin using either siRNA knockdown or a dominant negative mutant abrogates the enhanced CXCL12-dependent migration of CXCR4/CXCR7-expressing cells. These results show how CXCR7, which cannot signal directly through G protein-linked pathways, can nevertheless affect cellular signaling networks by forming a heteromeric complex with CXCR4. The CXCR4·CXCR7 heterodimer complex recruits β-arrestin, resulting in preferential activation of β-arrestin-linked signaling pathways over canonical G protein pathways. CXCL12-dependent signaling of CXCR4 and its role in cellular physiology, including cancer metastasis, should be evaluated in the context of potential functional hetero-oligomerization with CXCR7. G protein-coupled receptor hetero-oligomerization is emerging as an important regulator of ligand-dependent transmembrane signaling, but precisely how receptor heteromers affect receptor pharmacology remains largely unknown. In this study, we have attempted to identify the functional significance of the heteromeric complex between CXCR4 and CXCR7 chemokine receptors. We demonstrate that co-expression of CXCR7 with CXCR4 results in constitutive recruitment of β-arrestin to the CXCR4·CXCR7 complex and simultaneous impairment of Gi-mediated signaling. CXCR7/CXCR4 co-expression also results in potentiation of CXCL12 (SDF-1)-mediated downstream β-arrestin-dependent cell signaling pathways, including ERK1/2, p38 MAPK, and SAPK as judged from the results of experiments using siRNA knockdown to deplete β-arrestin. Interestingly, CXCR7/CXCR4 co-expression enhances cell migration in response to CXCL12 stimulation. Again, inhibition of β-arrestin using either siRNA knockdown or a dominant negative mutant abrogates the enhanced CXCL12-dependent migration of CXCR4/CXCR7-expressing cells. These results show how CXCR7, which cannot signal directly through G protein-linked pathways, can nevertheless affect cellular signaling networks by forming a heteromeric complex with CXCR4. The CXCR4·CXCR7 heterodimer complex recruits β-arrestin, resulting in preferential activation of β-arrestin-linked signaling pathways over canonical G protein pathways. CXCL12-dependent signaling of CXCR4 and its role in cellular physiology, including cancer metastasis, should be evaluated in the context of potential functional hetero-oligomerization with CXCR7.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer
Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K. J., Mehra, R., Loberg, R., & Taichman, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707465200 · Cited by 457
RetractedInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes
Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. C., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., & Bachelerie, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508234200 · Cited by 1,040
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature Reviews Immunology · doi:10.1038/nri722 · Cited by 752
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702229104 · Cited by 624
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
Björndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., Albert, J., Scarlatti, G., Littman, D. R., & Fenyö, E. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7478-7487.1997 · Cited by 606
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., & Lefkowitz, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912852107 · Cited by 600
Miao, Z., Luker, K. E., Summers, B. C., Berahovich, R., Bhojani, M. S., Rehemtulla, A., Kleer, C. G., Essner, J. J., Nasevicius, A., Luker, G. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610444104 · Cited by 533
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508
Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
Mellado, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2497 · Cited by 432
Zlotnik, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22024 · Cited by 421
Sun, Y., Cheng, Z., Ma, L., & Pei, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207294200 · Cited by 382
Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice
Fong, A. M., Premont, R. T., Richardson, R. M., Yu, Y.-R. A., Lefkowitz, R. J., & Patel, D. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112198299 · Cited by 311
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Kalatskaya, I., Berchiche, Y. A., Gravel, S., Limberg, B. J., Rosenbaum, J. S., & Heveker, N. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053389 · Cited by 309
Hattermann, K., Held-Feindt, J., Lucius, R., Müerköster, S. S., Penfold, M. E. T., Schall, T. J., & Mentlein, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3642 · Cited by 295
Zabel, B. A., Wang, Y., Lewén, S., Berahovich, R. D., Penfold, M. E. T., Zhang, P., Powers, J., Summers, B. C., Miao, Z., Zhao, B., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900269 · Cited by 294
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Veldkamp, C. T., Seibert, C., Peterson, F. C., De la Cruz, N. B., Haugner, J. C., Basnet, H., Sakmar, T. P., & Volkman, B. F. (2008) · Science Signaling · doi:10.1126/scisignal.1160755 · Cited by 287
Self-citationMazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S., Becherucci, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071903 · Cited by 264
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes
Ye, S., Zaitseva, E., Caltabiano, G., Schertler, G. F. X., Sakmar, T. P., Deupi, X., & Vogel, R. (2010) · Nature · doi:10.1038/nature08948 · Cited by 263
Self-citationPercherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., & Heveker, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411151200 · Cited by 261
CXCR7, CXCR4 and CXCL12: An eccentric trio?
Thelen, M., & Thelen, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.020 · Cited by 245
Rozenfeld, R., & Devi, L. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7793com · Cited by 220
Cheng, Z.-J., Zhao, J., Sun, Y., Hu, W., Wu, Y.-L., Cen, B., Wu, G.-X., & Pei, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2479 · Cited by 219
Alkhatib, G. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328324bbec · Cited by 208
Ge, L., Ly, Y., Hollenberg, M., & DeFea, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300573200 · Cited by 205
Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers
El-Asmar, L., Springael, J.-Y., Ballet, S., Andrieu, E. U., Vassart, G., & Parmentier, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003624 · Cited by 195
Ge, L., Shenoy, S. K., Lefkowitz, R. J., & DeFea, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410312200 · Cited by 177
CXCR4 mediates the proliferation of glioblastoma progenitor cells
Ehtesham, M., Mapara, K. Y., Stevenson, C. B., & Thompson, R. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.034 · Cited by 171
Involvement of Chemokine Receptors in Organ-Specific Metastasis
Zlotnik, A. (2006) · Contributions to Microbiology · doi:10.1159/000092973 · Cited by 159
Terrillon, S., Barberis, C., & Bouvier, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305322101 · Cited by 158
Ulvmar, M. H., Hub, E., & Rot, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.012 · Cited by 156
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
Sohy, D., Parmentier, M., & Springael, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705302200 · Cited by 153
Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4
Décaillot, F. M., Rozenfeld, R., Gupta, A., & Devi, L. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804106105 · Cited by 152
Self-citationSpringael, J., Minh, P. N. L., Urizar, E., Costagliola, S., Vassart, G., & Parmentier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019414 · Cited by 142
Raggo, C. M., Ruhl, R. A., McAllister, S. C., Koon, H. B., Dezube, B. J., Früh, K., & Moses, A. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2822 · Cited by 126
The chemokine receptors CXCR4 and CXCR3 in cancer
Fulton, A. M. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0019-1 · Cited by 116
Banerjee, S., Huber, T., & Sakmar, T. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.066 · Cited by 113
Self-citationImaging chemokine receptor dimerization with firefly luciferase complementation
Luker, K. E., Gupta, M., & Luker, G. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-116749 · Cited by 109
Imaging Ligand-Dependent Activation of CXCR7
Luker, K. E., Gupta, M., Steele, J. M., Foerster, B. R., & Luker, G. D. (2009) · Neoplasia · doi:10.1593/neo.09724 · Cited by 105
Iwakiri, S., Mino, N., Takahashi, T., Sonobe, M., Nagai, S., Okubo, K., Wada, H., Date, H., & Miyahara, R. (2009) · Cancer · doi:10.1002/cncr.24281 · Cited by 102
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21
Byers, M. A., Calloway, P. A., Shannon, L., Cunningham, H. D., Smith, S. E., Li, F., Fassold, B. C., & Vines, C. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4723 · Cited by 98
Monomeric Rhodopsin Is the Minimal Functional Unit Required for Arrestin Binding
Tsukamoto, H., Sinha, A., DeWitt, M. A., & Farrens, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.029 · Cited by 95
CXCL12/CXCR4 promotes motility and proliferation of glioma cells
do Carmo, A., Patricio, I., Cruz, M. T., Carvalheiro, H., Oliveira, C. R., & Lopes, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10342 · Cited by 93
CXCL12, CXCR4 and CXCR7 expression in brain metastases
Salmaggi, A., Maderna, E., Calatozzolo, C., Gaviani, P., Canazza, A., Milanesi, I. M., Silvani, A., DiMeco, F., Carbone, A., & Pollo, B. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.17.9202 · Cited by 91
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7
Gravel, S., Malouf, C., Boulais, P. E., Berchiche, Y. A., Oishi, S., Fujii, N., Leduc, R., Sinnett, D., & Heveker, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.147470 · Cited by 85
Expression of the new CXCL12 receptor, CXCR7, in gliomas
Calatozzolo, C., Canazza, A., Pollo, B., Pierro, E. A. D., Ciusani, E., Maderna, E., Salce, E., Sponza, V., Frigerio, S., DiMeco, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13951 · Cited by 57
Chemokine receptors and other G protein-coupled receptors
Lodowski, D. T., & Palczewski, K. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283223d8d · Cited by 53
The Role of Chemokines in the Biology and Therapy of Breast Cancer
Walser, T. C., & Fulton, A. M. (2004) · Breast Disease · doi:10.3233/bd-2004-20114 · Cited by 27
Chu, Y., Yang, X., Xu, W., Wang, Y., Guo, Q., & Xiong, S. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0296-1 · Cited by 24
Cited by
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Ding, B.-S., Cao, Z., Lis, R., Nolan, D. J., Guo, P., Simons, M., Penfold, M. E., Shido, K., Rabbany, S. Y., & Rafii, S. (2014) · Nature · doi:10.1038/nature12681 · Cited by 626
Immune regulation by atypical chemokine receptors
Nibbs, R. J. B., & Graham, G. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3544 · Cited by 407
The unique structural and functional features of CXCL12
Janssens, R., Struyf, S., & Proost, P. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.107 · Cited by 378
Metadata
- Authors
- Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 286
- Issue
- 37
- Pages
- 32188-32197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035832696
- Cited by
- 333
- References
- 62
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.